Nov 27, 2024 | Defective Drugs, Defective Medical Device, Personal Injury, Product Liability, Tepezza Injuries
Tepezza, a medication approved by the FDA in 2020 for the treatment of thyroid eye disease (TED), has been a game-changer for individuals suffering from this rare and debilitating condition. However, alongside its success in managing symptoms of TED, growing concerns...
Aug 6, 2024 | Defective Drugs, Defective Product, Medical News, Product Liability
Tepezza (teprotumumab) has emerged as a groundbreaking treatment for Thyroid Eye Disease (TED), a condition that can cause bulging eyes, double vision, and other serious issues. While Tepezza has offered hope to many patients, it has also raised concerns due to...
Jul 25, 2024 | Defective Drugs, Defective Product, Medical News, Personal Injury, Product Liability
In recent years, Tepezza, a groundbreaking treatment for Thyroid Eye Disease (TED), has offered hope to many patients suffering from this debilitating condition. However, as its usage has increased, so too have reports of severe side effects, particularly those...
